BR112013003469A2 - agente de formação de imagem, composição de agente de formação de imagem, composição farmacêutica, precursor,e, métodos de preparação do peptídeo cíclico, de preparação da composição, e de formação de imagem do corpo de mamífero in vivo. - Google Patents
agente de formação de imagem, composição de agente de formação de imagem, composição farmacêutica, precursor,e, métodos de preparação do peptídeo cíclico, de preparação da composição, e de formação de imagem do corpo de mamífero in vivo.Info
- Publication number
- BR112013003469A2 BR112013003469A2 BR112013003469A BR112013003469A BR112013003469A2 BR 112013003469 A2 BR112013003469 A2 BR 112013003469A2 BR 112013003469 A BR112013003469 A BR 112013003469A BR 112013003469 A BR112013003469 A BR 112013003469A BR 112013003469 A2 BR112013003469 A2 BR 112013003469A2
- Authority
- BR
- Brazil
- Prior art keywords
- composition
- imaging
- preparation
- imaging agent
- vivo
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1833—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nuclear Medicine (AREA)
Abstract
agente de formação de imagem, composição de agente de formação de imagem, composição farmacêutica, precursor, e, métodos de preparação do peptídeo cíclico, de preparação da composição, e de formação de imagem do corpo mamífero in vivo. a presente invenção diz respeito às composições de agente de formação de imagem compreendendo peptídeos de ligação ao c-met radiomarcados, adequados para formação de imagem por tomografia por emissão de pósitron (pet) in vivo. os peptídeos de ligação ao c-met são marcados com o radioisótopo <sym>f. são também reveladas composições farmacêuticas, métodos de preparação dos agentes e composições, e métodos de formação de imagem in vivo usando as composições, especialmente para uso no controle do câncer.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1013808.9A GB201013808D0 (en) | 2010-08-18 | 2010-08-18 | Peptide radiotracer compositions |
PCT/EP2011/063890 WO2012022676A1 (en) | 2010-08-18 | 2011-08-11 | Peptide radiotracer compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112013003469A2 true BR112013003469A2 (pt) | 2016-06-21 |
Family
ID=42938098
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112013003469A BR112013003469A2 (pt) | 2010-08-18 | 2011-08-11 | agente de formação de imagem, composição de agente de formação de imagem, composição farmacêutica, precursor,e, métodos de preparação do peptídeo cíclico, de preparação da composição, e de formação de imagem do corpo de mamífero in vivo. |
Country Status (18)
Country | Link |
---|---|
US (1) | US9533059B2 (pt) |
EP (1) | EP2605802B1 (pt) |
JP (1) | JP6014592B2 (pt) |
KR (1) | KR101853993B1 (pt) |
CN (1) | CN103153350B (pt) |
AU (1) | AU2011290856B2 (pt) |
BR (1) | BR112013003469A2 (pt) |
CA (1) | CA2807491C (pt) |
CL (1) | CL2013000483A1 (pt) |
ES (1) | ES2626410T3 (pt) |
GB (1) | GB201013808D0 (pt) |
IL (1) | IL224463A (pt) |
MX (1) | MX348733B (pt) |
MY (1) | MY163136A (pt) |
NZ (1) | NZ606466A (pt) |
RU (1) | RU2594167C2 (pt) |
SG (1) | SG187878A1 (pt) |
WO (1) | WO2012022676A1 (pt) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201103696D0 (en) * | 2011-03-04 | 2011-04-20 | Ge Healthcare Ltd | Technetium labelled peptides |
GB201121914D0 (en) | 2011-12-20 | 2012-02-01 | Ge Healthcare Ltd | Method for patient selection |
GB201209082D0 (en) * | 2012-05-24 | 2012-07-04 | Ge Healthcare Ltd | Purification method |
GB201221266D0 (en) * | 2012-11-27 | 2013-01-09 | Ge Healthcare Ltd | Aldehyde compositions |
GB201314936D0 (en) | 2013-08-21 | 2013-10-02 | Ge Healthcare Ltd | Radiolabelling method |
GB201322456D0 (en) * | 2013-12-18 | 2014-02-05 | Ge Healthcare Ltd | Radiotracer compositions and methods |
GB201322451D0 (en) * | 2013-12-18 | 2014-02-05 | Ge Healthcare Ltd | Purification method and compositions |
WO2018022603A1 (en) * | 2016-07-25 | 2018-02-01 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Methods of making 18f-labeled precursors and peptides, labeled c-met binding peptides, and methods of use thereof |
GB201804835D0 (en) * | 2018-03-26 | 2018-05-09 | Ge Healthcare As | Formulation and method of preparation |
WO2020249980A1 (en) | 2019-06-14 | 2020-12-17 | Edinburgh Molecular Imaging Limited | Compounds and methods of use |
GB201915206D0 (en) * | 2019-10-21 | 2019-12-04 | Ge Healthcare Ltd | Use of cyclodextrins as a radiostabilizer |
SE2050387A1 (en) * | 2020-04-06 | 2021-10-07 | Pvac Medical Tech Ltd | Labelled substance and methods of detection of inflammation and infection using said substance |
TW202305012A (zh) * | 2021-03-22 | 2023-02-01 | 日商肽夢想股份有限公司 | c-Met 蛋白質結合肽複合物 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5961955A (en) * | 1997-06-03 | 1999-10-05 | Coulter Pharmaceutical, Inc. | Radioprotectant for peptides labeled with radioisotope |
US20050118165A1 (en) | 2001-12-27 | 2005-06-02 | Van Andel Institute; And The Usa As Represented By The Department Of Veterans Affairs | Monoclonal antibody imaging and therapy of tumors that express met and bind hepatocyte growth factor |
US20050214859A1 (en) * | 2003-03-03 | 2005-09-29 | Dyax Corp. | Peptides that specifically bind HGF receptor (cMet) and uses thereof |
GB0305704D0 (en) * | 2003-03-13 | 2003-04-16 | Amersham Plc | Radiofluorination methods |
GB0420344D0 (en) * | 2004-09-14 | 2004-10-13 | Amersham Plc | Diagnostic compounds |
JP2009542689A (ja) | 2006-07-07 | 2009-12-03 | ザ ボード オブ トラスティーズ オブ ザ リーランド スタンフォード ジュニア ユニバーシティ | 選択的カスパーゼ阻害剤 |
GB0615211D0 (en) | 2006-07-31 | 2006-09-06 | Ge Healthcare Uk Ltd | Asymmetric flouro-substituted polymethine dyes |
KR20090058553A (ko) | 2006-09-08 | 2009-06-09 | 바이엘 쉐링 파마 악티엔게젤샤프트 | 18f 표지된 작용제에 대한 화합물 및 방법 |
EP2099499A2 (en) | 2006-12-13 | 2009-09-16 | GE Healthcare AS | Synthesis of a radiofluorinated peptide using microwave activation technology |
US8216548B2 (en) * | 2006-12-28 | 2012-07-10 | Ge Healthcare As | Radiofluorination methods |
AU2007348145A1 (en) | 2007-03-01 | 2008-09-04 | Bayer Schering Pharma Aktiengesellschaft | 18F fluoro-benzoyl labelled biological active coumpounds as diagnositic imaging agents as well as benzotriazol-1-yloxy-benzoyl, 2,5-dioxo-pyrrolidin-1-yloxy) benzoyl and trimethylammonio-benzoyl precursers |
KR20150017387A (ko) | 2007-05-16 | 2015-02-16 | 지이 헬스케어 에이에스 | 영상화를 위한 표지된 hgf 결합성 펩티드 |
GB0718957D0 (en) * | 2007-09-28 | 2007-11-07 | Ge Healthcare Ltd | Optical imaging agents |
GB0718967D0 (en) | 2007-09-28 | 2007-11-07 | Ge Healthcare Ltd | Peptide imaging agents |
GB0716897D0 (en) * | 2007-08-30 | 2007-10-10 | Univ Muenchen Tech | Cancer imaging and treatment |
GB0803477D0 (en) * | 2008-02-26 | 2008-04-02 | Ge Healthcare As | Therapy selection method |
-
2010
- 2010-08-18 GB GBGB1013808.9A patent/GB201013808D0/en not_active Ceased
-
2011
- 2011-08-11 JP JP2013524419A patent/JP6014592B2/ja active Active
- 2011-08-11 CA CA2807491A patent/CA2807491C/en active Active
- 2011-08-11 AU AU2011290856A patent/AU2011290856B2/en active Active
- 2011-08-11 NZ NZ606466A patent/NZ606466A/en unknown
- 2011-08-11 KR KR1020137006689A patent/KR101853993B1/ko active IP Right Grant
- 2011-08-11 US US13/816,589 patent/US9533059B2/en active Active
- 2011-08-11 CN CN201180050137.2A patent/CN103153350B/zh active Active
- 2011-08-11 EP EP11744007.3A patent/EP2605802B1/en active Active
- 2011-08-11 ES ES11744007.3T patent/ES2626410T3/es active Active
- 2011-08-11 MY MYPI2013700257A patent/MY163136A/en unknown
- 2011-08-11 BR BR112013003469A patent/BR112013003469A2/pt active Search and Examination
- 2011-08-11 RU RU2013105491/04A patent/RU2594167C2/ru active
- 2011-08-11 SG SG2013011770A patent/SG187878A1/en unknown
- 2011-08-11 WO PCT/EP2011/063890 patent/WO2012022676A1/en active Application Filing
- 2011-08-11 MX MX2013001939A patent/MX348733B/es active IP Right Grant
-
2013
- 2013-01-29 IL IL224463A patent/IL224463A/en active IP Right Grant
- 2013-02-18 CL CL2013000483A patent/CL2013000483A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
NZ606466A (en) | 2014-11-28 |
GB201013808D0 (en) | 2010-09-29 |
AU2011290856A1 (en) | 2013-03-14 |
KR101853993B1 (ko) | 2018-05-02 |
SG187878A1 (en) | 2013-03-28 |
MX348733B (es) | 2017-06-27 |
IL224463A (en) | 2016-05-31 |
RU2594167C2 (ru) | 2016-08-10 |
CN103153350A (zh) | 2013-06-12 |
CN103153350B (zh) | 2016-06-29 |
US20130149241A1 (en) | 2013-06-13 |
EP2605802A1 (en) | 2013-06-26 |
ES2626410T3 (es) | 2017-07-25 |
JP6014592B2 (ja) | 2016-10-25 |
MX2013001939A (es) | 2013-03-18 |
KR20130135242A (ko) | 2013-12-10 |
AU2011290856B2 (en) | 2014-12-04 |
JP2013540702A (ja) | 2013-11-07 |
MY163136A (en) | 2017-08-15 |
RU2013105491A (ru) | 2014-09-27 |
CA2807491A1 (en) | 2012-02-23 |
US9533059B2 (en) | 2017-01-03 |
CA2807491C (en) | 2019-06-04 |
WO2012022676A1 (en) | 2012-02-23 |
EP2605802B1 (en) | 2017-04-26 |
CL2013000483A1 (es) | 2014-03-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112013003469A2 (pt) | agente de formação de imagem, composição de agente de formação de imagem, composição farmacêutica, precursor,e, métodos de preparação do peptídeo cíclico, de preparação da composição, e de formação de imagem do corpo de mamífero in vivo. | |
BR112016005802A2 (pt) | conjugados de clorotoxina e métodos de seu uso | |
PH12015501092A1 (en) | Anti-ceacam5 antibodies and uses thereof | |
BR112014026531A2 (pt) | proteínas de ligação de antígeno ligando cd30 humano | |
EP3916091A3 (en) | Dry powder composition comprising long-chain rna | |
UY32037A (es) | Daa-piridina | |
CY1119616T1 (el) | Συζευγματα ανθρωπινου αντισωματος-φαρμακου κατα του ιστικου παραγοντα | |
CY1119582T1 (el) | Υδατικα παρασκευασματα ινσουλινης, που περιεχουν μεθειονινη | |
JOP20150245B1 (ar) | صياغات ذات مفعول طويل من الأنسولين | |
BR112012026471A2 (pt) | conjugado, processo para a síntese do mesmo, método para imagem de uma célula que expressa um transportador de neurotransmissor que compreende o contato da referida célula com o conjugado, processo para preparar um comporto de fórmula (ii) e (xiv) e composto | |
BRPI0907087A2 (pt) | ácidos nucleicos de fórmula (i) (nuglxmgnnv)a e derivados dos mesmos como um agente imunoestimulante/adjuvante | |
BR112012027315A8 (pt) | polipeptídeo quimérico, composição, molécula de ácido nucleico quimérica, vetor, célula hospedeira, processo de produção de um polipeptídeo, vacina combinada, e, métodos para a indução de uma resposta imunológica e para prevenir ou tratar uma infecção ou doença | |
PE20120563A1 (es) | Construcciones novedosas de proteina del virus de papiloma humano (hpv) y su uso en la prevencion de la enfermedad por el hpv | |
MY150757A (en) | Click chemistry-derived cyclopeptide derivatives as imaging agents for integrins | |
MX2013010012A (es) | Analogos de octreotato radiomarcado como trazadores de tomografia por emision de positrones. | |
MX2013012793A (es) | Aminoacidos radiomarcados para imagen de diagnostico. | |
BR112015012366A8 (pt) | antagonistas de cxcr7, uso dos mesmos, composição farmacêutica, bem como métodos para detectar níveis elevados de cxcr7 em uma amostra e para imagear um tumor, órgão, ou tecido | |
BR112013029417A2 (pt) | composições de vacina de matriz proteica incluindo policátions | |
EA201291044A1 (ru) | Слитый белок robo1-fc и его применение в лечении опухолей | |
CL2009001240A1 (es) | Compuestos derivados del acido l-glutamico y l-glutamina marcados con [f-18]; procedimiento de preparacion; composicion farmaceutica que comprende a los compuestos y su uso como agentes en el diagnostico de tumores. | |
MX2011010295A (es) | Reactivos de radiomarcado y metodos. | |
GB201103696D0 (en) | Technetium labelled peptides | |
BR112012027463A2 (pt) | método terapêutico, composição farmacêutica, uso de tri-iodotironina (t3) ou de análogo bioquímico da mesma, tri-iodotironina (t3) ou um análogo bioquímico da mesma, e, kit | |
CL2009001238A1 (es) | Compuestos derivados de acido l-glutamico marcado con [f-18] y derivados de l-glutamina marcada con [f-18]; procedimiento de preparacion; conjunto de diagnostico por imagenes; composiciones farmaceuticas; y uso para el diagnostico por imagenes de enfermedades tumorales. | |
BR112015018200A2 (pt) | composição mastigável para administração oral e processo para preparar a mesma |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07G | Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette] | ||
B08F | Application fees: application dismissed [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 8A ANUIDADE. |